<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Danaher Corp.</title>
	<atom:link href="http://www.stockbloghub.com/tag/danaher-corp/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(TMO) Thermo Fisher Scientific Inc Buys BRAHMS</title>
		<link>http://www.stockbloghub.com/2009/09/10/tmo-thermo-fisher-scientific-inc-buys-brahms/14834</link>
		<comments>http://www.stockbloghub.com/2009/09/10/tmo-thermo-fisher-scientific-inc-buys-brahms/14834#comments</comments>
		<pubDate>Thu, 10 Sep 2009 22:06:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Danaher Corp.]]></category>
		<category><![CDATA[DHR]]></category>
		<category><![CDATA[Thermo Fisher Scientific Inc]]></category>
		<category><![CDATA[TMO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=14834</guid>
		<description><![CDATA[Thermo Fisher Scientific Inc. (TMO) recently agreed to acquire B.R.A.H.M.S. AG for 330 million Euros or about $470 million. B.R.A.H.M.S. is a leading provider of specialty in-vitro diagnostic tests based on its patented biomarkers for sepsis, cardiovascular and pulmonary diseases, as well as intensive care treatments and prenatal screening. The company is based outside of Berlin in Hennigsdorf, Germany, and has sales offices in Europe and the U.S. With nearly 400 employees serving customers in 65 countries around the world, B.R.A.H.M.S. generated 2008 sales of 75 million Euros or about $105 million. The transaction is expected to be accretive to earnings in 2010. The news comes a day after diversified US manufacturer Danaher Corp. (DHR) said it would buy two scientific instrument businesses for a total of $1.1 billion. B.R.A.H.M.S. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/09/10/tmo-thermo-fisher-scientific-inc-buys-brahms/14834/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DHR) Danaher Expands in Life Sciences</title>
		<link>http://www.stockbloghub.com/2009/09/02/dhr-danaher-expands-in-life-sciences/14196</link>
		<comments>http://www.stockbloghub.com/2009/09/02/dhr-danaher-expands-in-life-sciences/14196#comments</comments>
		<pubDate>Wed, 02 Sep 2009 19:44:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Conglomerates]]></category>
		<category><![CDATA[Danaher Corp.]]></category>
		<category><![CDATA[DHR]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[Life Technologies Corporation]]></category>
		<category><![CDATA[MDS]]></category>
		<category><![CDATA[MDZ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=14196</guid>
		<description><![CDATA[Earlier today, Danaher Corp. (DHR) announced its decision to acquire the Analytical Technologies division of MDS Inc. (MDZ). This includes a 50% stake in Applied Biosystems/MDS Sciex joint venture (AB SCIEX), and a 100% ownership in the former Molecular Devices Corp. The company has also reached an agreement with Life Technologies Corp. (LIFE) to acquire the remaining 50% ownership position in AB SCIEX. AB SCIEX designs and manufactures mass spectrometers, highly sensitive and sophisticated instruments used by researchers and clinicians. It sells its products to academic and research institutions, pharmaceutical development labs primarily supporting clinical trials, testing and reference labs and hospitals. Molecular Devices is a bioresearch and analytical instrumentation company. Danaher will pay a total of $1.1 billion for a full ownership of both these businesses. The acquired businesses ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/09/02/dhr-danaher-expands-in-life-sciences/14196/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ALGN) Align Technology Faces Class Action Lawsuit</title>
		<link>http://www.stockbloghub.com/2009/08/21/algn-align-technology-faces-class-action-lawsuit/13127</link>
		<comments>http://www.stockbloghub.com/2009/08/21/algn-align-technology-faces-class-action-lawsuit/13127#comments</comments>
		<pubDate>Sat, 22 Aug 2009 01:43:30 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ALGN]]></category>
		<category><![CDATA[Align Technology Incorporated]]></category>
		<category><![CDATA[Danaher Corp.]]></category>
		<category><![CDATA[Dentsply International Incorporated]]></category>
		<category><![CDATA[DHR]]></category>
		<category><![CDATA[XRAY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=13127</guid>
		<description><![CDATA[Align Technology, Inc. (ALGN) faces another lawsuit after settling a long-pending litigation with Ormco Corporation, a subsidiary of Danaher Corporation (DHR). The new litigation is concerned with the company&#8217;s operations way back in the third quarter of 2007. The class action lawsuit was filed by the Law Offices of Howard G. Smith, on behalf of the company&#8217;s investors, who purchased the company&#8217;s common stock between Jan 30, 2007 and Oct 24, 2007 Incorporatedlusive. The complaint charges Align and its CEO of violating federal securities laws. The complaint alleges that throughout the above-mentioned period, also known as the Class period, the defendants knew or irresponsibly disregarded and failed to disclose that the company had shifted the focus of its sales force to clearing backlog, resulting in a decline in the number ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/21/algn-align-technology-faces-class-action-lawsuit/13127/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ALGN) Align Settles Litigation &#8211; new strategic collaboration with Ormco</title>
		<link>http://www.stockbloghub.com/2009/08/20/dhr-align-settles-litigation-new-strategic-collaboration-with-ormco/12833</link>
		<comments>http://www.stockbloghub.com/2009/08/20/dhr-align-settles-litigation-new-strategic-collaboration-with-ormco/12833#comments</comments>
		<pubDate>Thu, 20 Aug 2009 19:01:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ALGN]]></category>
		<category><![CDATA[Align Technology Incorporated]]></category>
		<category><![CDATA[Danaher Corp.]]></category>
		<category><![CDATA[Dentsply International Incorporated]]></category>
		<category><![CDATA[DHR]]></category>
		<category><![CDATA[XRAY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=12833</guid>
		<description><![CDATA[Align Technology, Inc. (ALGN) has settled all pending litigations and begun a new strategic collaboration with Ormco Corporation, a subsidiary of Danaher Corporation (DHR). Shares of Align reacted positively to this news with the price increasing roughly 28% to close at $13.00 on August 17. It has traded above the $13 level almost the entire time since. Per the settlement, Ormco has agreed to release all its past claims related to the 444 patent and will not sue Align in future regarding same. Align will provide Ormco roughly $13 million in cash and will issue 7.6 million shares of its common stock to Ormco’s parent company, Danaher. The stock issuance will result in Danaher having approximately 10% ownership of Align post-issuance. The settlement is a relief for Align as it ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/08/20/dhr-align-settles-litigation-new-strategic-collaboration-with-ormco/12833/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DHR) Danaher  Corporation: Stock  of the Day</title>
		<link>http://www.stockbloghub.com/2009/01/29/dhr-danaher-corporation-stock-of-the-day/2404</link>
		<comments>http://www.stockbloghub.com/2009/01/29/dhr-danaher-corporation-stock-of-the-day/2404#comments</comments>
		<pubDate>Fri, 30 Jan 2009 00:04:01 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Conglomerates]]></category>
		<category><![CDATA[Danaher Corp.]]></category>
		<category><![CDATA[DHR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=2404</guid>
		<description><![CDATA[Matt Weinschenk, Senior Analyst, The White Cap Report The markets have been in uncharted territory for the last eight months or so. Despite everyone’s opinion on “what to do with your money today”, there’s no proven playbook for this specific market. But that shouldn’t bother you. In fact, it should be motivating that the “experts” don’t have a clue of what to do next. And their confusion spells opportunity for us. Even though we may not be at the bottom, it’s about time to start scooping up high-quality companies at value prices… or at the very least start building up your stock watchlist. Consider adding Danaher Corp (NYSE: DHR) to that watchlist today. Danaher Corp is a conglomerate that produces everything from ultraviolet disinfection systems to Craftsman tools. They operate ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/01/29/dhr-danaher-corporation-stock-of-the-day/2404/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

